Seegene has raised concerns regarding the limitations of virus-only testing in diagnosing pneumonia-associated bacterial respiratory pathogens. The company emphasizes that relying solely on tests that identify viral infections may overlook significant bacterial causes of pneumonia, which could lead to inadequate patient treatment.
In light of these findings, Seegene calls for a transition to comprehensive syndromic PCR testing. This approach would enable the simultaneous detection of both viral and bacterial pathogens, improving diagnostic accuracy and patient outcomes. By employing a more holistic testing strategy, healthcare providers can ensure that patients receive appropriate and timely treatment for respiratory infections.
The move towards comprehensive testing is particularly critical given the rising incidence of pneumonia and its associated complications. Seegene’s advocacy highlights the need for healthcare systems to adapt their diagnostic practices to better reflect the complexities of respiratory infections.
Source: news.google.com